Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · IEX Real-Time Price · USD
18.93
-1.98 (-9.47%)
At close: Jul 2, 2024, 4:00 PM
17.86
-1.07 (-5.65%)
After-hours: Jul 2, 2024, 6:31 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.22 billion as of July 2, 2024. Its market cap has increased by 156.53% in one year.
Market Cap
1.22B
Enterprise Value
1.00B
1-Year Change
156.53%
Ranking
Category
Stock Price
$18.93
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.10M to $1.22B, an increase of 73.02%. That is a compound annual growth rate of 14.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.03B | 105.29% |
| Dec 29, 2023 | 500.60M | -3.30% |
| Dec 30, 2022 | 517.70M | -59.91% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.37B |
| Belite Bio | 1.37B |
| Arcus Biosciences | 1.37B |
| Avadel Pharmaceuticals | 1.36B |
| Disc Medicine | 1.35B |
| ANI Pharmaceuticals | 1.32B |
| AdaptHealth | 1.30B |
| Kiniksa Pharmaceuticals | 1.30B |